8th August 2025

CEL:JPJ

ISIN: GB00BDQYGP38

 

CELADON PHARMACEUTICALS PLC

 

("CEL" or "the Company")

 

Celadon Pharmaceuticals PLC shares are now trading on JP Jenkins

 

London, UK – 8th Aug 2025 – Celadon Pharmaceuticals PLC (CEL:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. Celadon Pharmaceuticals PLC, registered at 71-75 Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ (Company No. 11545912).

Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism.

 

The Company’s facility comprises an indoor hydroponic cultivation, proprietary GMP extraction and manufacturing and an analytical and R&D laboratory. It also has a minority interest in early-stage biopharma Kingdom therapeutics. The Company’s subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.

 

JP Jenkins provides a share trading venue for unlisted or unquoted companies, enabling shareholders and prospective investors to trade equity on a matched bargain basis. JP Jenkins operates as a trading name of InfinitX Limited and is an Appointed Representative of Prosper Capital LLP (FRN 453007). The indicative pricing for the ordinary shares, along with transaction history, will be available on the JP Jenkins website: https://jpjenkins.com.

 

For further information, please contact:

 

Celadon Pharmaceuticals PLC

Investor Relations:

Email: info@celadonpharma.co.uk

Tel: +44 (0)203 150 0252

 

JP Jenkins Ltd

Veronika Oswald / Mason Doick
Tel: +44 (0) 207 469 0937

Email: info@jpjenkins.com

 

-       End -